JP2024533162A5 - - Google Patents
Info
- Publication number
- JP2024533162A5 JP2024533162A5 JP2024513937A JP2024513937A JP2024533162A5 JP 2024533162 A5 JP2024533162 A5 JP 2024533162A5 JP 2024513937 A JP2024513937 A JP 2024513937A JP 2024513937 A JP2024513937 A JP 2024513937A JP 2024533162 A5 JP2024533162 A5 JP 2024533162A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163240220P | 2021-09-02 | 2021-09-02 | |
| US63/240,220 | 2021-09-02 | ||
| PCT/US2022/042448 WO2023034564A2 (en) | 2021-09-02 | 2022-09-02 | Anti-cd33 antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024533162A JP2024533162A (ja) | 2024-09-12 |
| JP2024533162A5 true JP2024533162A5 (https=) | 2025-09-09 |
| JPWO2023034564A5 JPWO2023034564A5 (https=) | 2025-09-09 |
Family
ID=85412855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513937A Pending JP2024533162A (ja) | 2021-09-02 | 2022-09-02 | 抗ｃｄ３３抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240262910A1 (https=) |
| EP (1) | EP4396235A4 (https=) |
| JP (1) | JP2024533162A (https=) |
| CN (1) | CN118234750A (https=) |
| AU (1) | AU2022340645A1 (https=) |
| CA (1) | CA3228414A1 (https=) |
| WO (1) | WO2023034564A2 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008535823A (ja) * | 2005-03-25 | 2008-09-04 | キュラジェン コーポレイション | テネイシンの主要な抗原に対する抗体 |
| DK2356270T3 (da) * | 2008-11-07 | 2016-12-12 | Fabrus Llc | Kombinatoriske antistofbiblioteker og anvendelser deraf |
| JO3246B1 (ar) * | 2009-09-09 | 2018-03-08 | Regeneron Pharma | اجسام مضادة بشرية ذات ألفة تفاعل عالية مع مستقبل 2 المفعل بالبروتين البشري |
| JP6488520B2 (ja) * | 2013-08-20 | 2019-03-27 | 国立研究開発法人科学技術振興機構 | ヒト抗体κ型軽鎖複合体含有組成物及びその製造方法 |
| TWI702229B (zh) * | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| AU2017252233A1 (en) * | 2016-04-22 | 2018-11-15 | Alligator Bioscience Ab | Novel bispecific polypeptides against CD137 |
| JOP20190116A1 (ar) * | 2018-05-24 | 2019-11-24 | Janssen Biotech Inc | الأجسام المضادة لتكتل التمايز 33 (cd33)، والأجسام المضادة ثنائية النوعية لتكتل التمايز 33 (cd33)/تكتل التمايز 3 (cd3) واستخداماتها |
| JP7303314B2 (ja) * | 2019-01-18 | 2023-07-04 | ヤンセン バイオテツク，インコーポレーテツド | Ｇｐｒｃ５ｄキメラ抗原受容体及びそれを発現する細胞 |
-
2022
- 2022-09-02 AU AU2022340645A patent/AU2022340645A1/en active Pending
- 2022-09-02 CA CA3228414A patent/CA3228414A1/en active Pending
- 2022-09-02 EP EP22865602.1A patent/EP4396235A4/en active Pending
- 2022-09-02 JP JP2024513937A patent/JP2024533162A/ja active Pending
- 2022-09-02 CN CN202280069909.5A patent/CN118234750A/zh active Pending
- 2022-09-02 WO PCT/US2022/042448 patent/WO2023034564A2/en not_active Ceased
-
2024
- 2024-02-29 US US18/592,427 patent/US20240262910A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024533162A5 (https=) | ||
| CL2025003762A1 (es) | Formulaciones que comprenden proteína de unión al transcripto 7 similar a inmunoglobulina. | |
| BR202022009269U2 (https=) | ||
| BR202022005961U2 (https=) | ||
| BY13165U (https=) | ||
| BY13170U (https=) | ||
| CN307047848S (https=) | ||
| CN307045635S (https=) | ||
| CN307045501S (https=) | ||
| CN307045090S (https=) | ||
| CN307045082S (https=) | ||
| CN307044896S (https=) | ||
| CN307044885S (https=) | ||
| CN307048138S (https=) | ||
| BY23963C1 (https=) | ||
| BY13141U (https=) | ||
| BY13175U (https=) | ||
| BY13174U (https=) | ||
| BY13172U (https=) | ||
| BY13162U (https=) | ||
| BY13169U (https=) | ||
| BY13168U (https=) | ||
| BY13167U (https=) | ||
| BY13166U (https=) | ||
| CN307045733S (https=) |